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ABSTRACT Previous studies have identified lipid-poor
high density lipoproteins with electrophoretic pre- -mobility
as the initial acceptors of cell-derived cholesterol in human
plasma. These lipoproteins contain apolipoprotein A-I (apoA-I)
as their sole apolipoprotein. In the present study, incubation of
human plasma with [3fcholesterol-laden skin fibroblasts has
led to the identification of another lipoprotein that serves as a
potent initial acceptor of cell-derived cholesterol. This lipopro-
tein, which we term -LpE, exhibits y mobility on agarose gel
electrophoresis. As determined by nondenaturing PAGE and
by electron microscopy, the size of the spherical particle ranges
between 12 and 16 am. SDS/PAGE and subsequent immuno
blotting Identied apoE as its sole apolipoprotein. Plasma from
normal and apoA-I-deflcdent mice, but not from apoE-deflcient
mice, released [3Hijcholesterol from fibroblasts into a -mi-
grating lipoprotein. Cell culture media from hepatoma cells or
mouse peritoneal macrophages, both of which contain apoE of
cellular origin, also promoted efflux of [3H~cholesterol from
fibroblasts into a migrting faction. his was not observed
with cell culture medium from fibroblasts alone. In conclusion,
our results strongly idcate the presence in human plasma of
alipoprotein containing only apoE, rLpE, which is secreted by
peripheral cells and is a potent acceptor of cell-derived cho-
lesterol.
Several epidemiological and clinical studies have revealed an
inverse correlation between the plasma concentration of high
density lipoprotein (HDL) cholesterol and the risk of myo-
cardial infarction (reviewed in ref. 1). The putative ability of
HDL to protect the vessel wall from atherosclerosis has
usually been explained by the reverse cholesterol transport
model in which HDL mediates the flux of excess cholesterol
from peripheral cells to the liver (reviewed in refs. 2-4). In the
extracellular compartment, this process is initiated by the
uptake of cholesterol from cell membranes by a subgroup of
small, discoidal, lipid-poor HDL containing only apolipopro-
tein A-I (apoA-I) and having pre-ps mobility upon electro-
phoresis (5). We previously reported that cell-derived cho-
lesterol is rapidly transferred from pre-(31-HDL to other
lipoproteins in the order pre-f2-HDL -* pre-P33-HDL -+
a-HDL -* low density lipoprotein (LDL) (6). The enzyme
lecithin-cholesterol acyltransferase directly esterifies a mi-
nor proportion of cell-derived cholesterol during its passage
through pre-P3-HDL; most cholesterol, however, is esterified
in a-HDL after it has recycled from LDL following transitory
storage with the latter lipoproteins (6). According to this
scheme, apoA-I is the central protein in the removal of
cholesterol from nonhepatic cells. Deficiency or severe re-
duction of apoA-I should therefore result in HDL deficiency
and increased coronary risk (1-4). However, we and others
have identified the molecular defects in several families with
apoA-I deficiency and familial lecithin-cholesterol acyltrans-
ferase deficiency in which, despite HDL deficiency in the
homozygous patients and one-half normal HDL-cholesterol
levels in heterozygotes, neither patients nor relatives were at
increased coronary risk (7-14). This paradox raises the
question as to whether proteins other than apoA-I might be
important for the removal of cellular cholesterol. During the
search for such proteins, we have now identified a previously
unknown lipid-poor lipoprotein in human plasma that serves
as a potent initial acceptor of cell-derived cholesterol. In
contrast to pre-(31-HDL, this lipoprotein contains only apoE
and exhibits ymobility upon electrophoresis. We have there-
fore termed it y-LpE.
MATERIALS AND METHODS
Plasma Sampls. Human plasma samples were obtained
from three normolipidemic probands after overnight fasting.
Streptokinase was used as the anticoagulant at a final con-
centration of 150 units/ml of blood. Mouse plasma was
obtained from normal, apoA-I-deficient, and apoE-deficient
mice by retro-orbital puncture and was anticoagulated by the
use of streptokinase at a final concentration of 1000 units/ml.
The apoA-I and apoE-deficient mice, described previously
(15, 16), were generated by gene targeting in embryonic stem
cells. The plasma concentration of unesterified cholesterol
(UC) in the plasma samples from normal, apoA-I-deficient,
and apoE-deficient mice amounted to 14.6 ± 0.8, 9.6 ± 2.6,
and 125.5 ± 4.5 mg/dl, respectively.
Cell Culture. Normal human skin fibroblasts were cultured
in Dulbecco's modified Eagle's medium (DMEM) containing
10%6 fetal calfserum in dishes 3.5-cm in diameter as described
(17). At the state of near confluence, cells in some dishes
were labeled in the presence offetal calfserum with 0.5 or 0.1
mCi (1 Ci = 37 GBq) of [1,2-3H]cholesterol ([3H]UC; New
England Nuclear; 51.7 Ci/mmol) for 72 hr at 37TC. The final
specific radioactivity in the washed cells was 2.7 ± 0.8 x 108
and 0.6 ± 0.2 x 108 cpm/mg of cell protein (mean ± SD),
respectively. Peritoneal macrophages were collected from
BALB/c mice- and cultured in DMEM as described (18).
Macrophage-conditioned medium was obtained by loading
macrophages with acetyl-LDL (100 ,g of protein) for 24 hr
followed by incubation for 24 hr with serum-free DMEM.
Similarly, HepG2 cell-conditioned medium or fibroblast-
conditioned medium was produced by incubating these cells
with serum free-medium for 24 hr.
Abbreviations: apoA, apoB, and apoE, apolipoproteins A, B, and E;
LpA and LpE, lipoproteins A and E; HDL, high density lipoprotein;
LDL, low density lipoprotein; UC, unesterified cholesterol.
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Pulse-Chase Incubations. After being washed six times
with phosphate-buffered saline (pH 7.4), radiolabeled cells
were incubated with 1 ml of plasma, conditioned cell culture
media, or purified y-tLpE (10 pg/ml in DMEM) for 1 min.
After a 1-min pulse incubation, plasma samples were re-
moved and either immediately used for agarose gel electro-
phoresis (see below) or directly transferred to another dish
with nonlabeled fibroblasts for another 1-min incubation
(chase). All experiments were performed in triplicate.
Electrophoresis. After pulse or chase incubations, plasma
samples were sometimes depleted of apoB-containing lipo-
proteins by incubation with phosphotungstic acid/MgCl2.
Aliquots of 20 of complete plasma or apoB-free plasma
were subjected to electrophoresis in 0.75% agarose gels at
40C for 2 hr at 40 mA and 300 V using a 50mM merbital buffer
[44.3 g of Tris/19.2 g of Merbital (Serva, Heidelberg,
F.R.G.)/0.5 g of calcium lactate/1 g of NaN3/1000 ml of
distilled water, pH 8.6]. Under these conditions, albumin,
which was made visible in the unstained gel by adding
bromophenol blue to the buffer, had migrated 7 cm. Every
lane of the gel was cut into segments of 0.5 cm in length.
Lipids were extracted from these slices by incubation with
chloroform/methanol (2:1, vol/vol) to determine radioactiv-
ity. Alternatively, lipoproteins in the agarose gel were stained
with fat red 7B or electroblotted onto nitrocellulose mem-
branes for immunodetection with goat antisera against
apoA-I, -A-II, -B, and -E (all from Boehringer Mannheim)
and against apoA-IV and apoC (raised in rabbits), biotinyl-
ated antibodies against IgG from goat and rabbit, respec-
tively, and streptavidin horseradish peroxidase (Amersham).
Lipoproteins migrating within the first 1 cm slice from the
starting point were separated in a nondenaturing 2-21%
polyacrylamide gradient gel and then electroblotted to nitro-
cellulose membrane for identification by polyclonal or mono-
clonal anti-apoE antisera (Boehringer Mannheim).
Isolation of yLpE. To characterize y-LpE, 40 ml ofplasma
was separated in several agarose gels. From every gel, a 1-cm
strip containing the proteins with y mobility was removed.
Proteins from several strips were eluted in phosphate-
buffered saline (pH 7.4) and run over an immunoaffinity
chromatography column in which purified IgG from anti-
apoE antiserum (Boehringer Mannheim) was conjugated to
CNBr-activated Sepharose CL-4B (Pharmacia). The bound
fraction was eluted with 0.2 M glycine/HCl, pH 3.0. After
extensive dialysis with 5 mM ammonium hydrogen carbon-
ate, the eluted lipoproteins were either stained directly for
electron microscopy or lyophilized and stored at -20°C.
Analysis of the Protein and Lipid Composition. Proteins
from y-tLpE were analyzed by SDS/PAGE (19). The lipids in
y-LpE were quantified using enzymatic photometric tests
(i.e., cholesterol and triglyceride with commercially available
enzymatic photometric tests from Boehringer Mannheim)
and phosphatidylcholine and sphingomyelin as described (20,
21). Total protein concentrations were measured according to
Lowry's method (22), using bovine serum albumin as the
standard.
RESULTS
Uptake of Cell-Derived Cholesterol by a y-Migrating Lipo-
protein in Human Plasma. Fig. 1 shows the distribution of
cell-derived radiolabeled cholesterol throughout human
plasma lipoproteins, which were separated by agarose gel
electrophoresis. After a 1-min pulse incubation of plasma
with radiolabeled fibroblasts, the percentage of [3H]UC in 3-,
pre-,-, and a-lipoproteins (Lp) amounted to 10% ± 2%, 24%
± 4%, and 34% ± 3%, respectively. The remaining 32% ± 5%
was unexpectedly found to be associated with proteins of 'y
mobility. After a 1-min chase incubation with nonlabeled
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FIG. 1. Distribution of cell-derived cholesterol in various lipo-
proteins separated by agarose gel electrophoresis. After a 1-min
pulse incubation with radiolabeled fibroblasts (a) or a further 1-min
chase incubation with nonlabeled cells (b), 20-pi aliquots of plasma
were subjected to electrophoresis in 0.75% agarose gels. The migra-
tion distances for lipoprotein standards were 0-10, 11-15, 16-45, and
50-65 mm for y-, f-, pre-,-, and a-Lp, respectively. After electro-
phoresis, each lane of the gel was cut into 5-mm-long segments. The
lipids in each slice were extracted with chloroform/methanol (2:1),
and their radioactivity was determined by liquid scintillation spec-
trometry. The values presented are the means ± SD of triplicate
experiments.
± 5% to 13% ± 3%, whereas [3H]UC increased in j3Lp to
20% ± 4% and in a-Lp to 50% ± 6%, respectively. Further-
more, fibroblasts labeled with [3H]UC were incubated with
plasma that had first been depleted of apoB-containing lipo-
proteins by phosphotungstic acid/MgCl2 precipitation. Un-
der these conditions, a 1-min pulse incubation still led to the
accumulation ofradioactivity in the yfraction. In 1-min chase
incubation experiments, the radiolabel consistently disap-
peared from this y fraction and appeared in a-Lp. These
results suggest the existence of a previously undetected
lipoprotein with y mobility upon agarose gel electrophoresis,
which participates in the very early uptake of cell-derived
cholesterol by plasma.
The protein moiety of this lipoprotein was identified using
anti-human apolipoprotein antibodies after electroblotting of
the agarose gels onto nitrocellulose membranes. Fig. 2a
presents anti-apoA-I and anti-apoE immunoblots. As ex-
pected, most of the anti-apoA-1 immunoreactivity was asso-
ciated with a-Lp, and only a small proportion was associated
with pre-P-Lp. Anti-apoE-immunoreactive material was
found not only in the a- and pre-,B fractions, as expected, but
also alone in the y fraction. Antisera to apoA-II, -A-IV, -B,
and -Cs failed to detect any proteins in the yfraction (data not
shown). To rule out cross-reactivity of human gamma glob-
ulins with the second biotinylated antibody used for immu-
nodetection, plasma was depleted ofIgG by the use ofprotein
G affinity chromatography before being separated by agarose
gel electrophoresis. Under these conditions, anti-apoE-
immunoreactive material was also detected in a fraction with
electrophoretic 'y mobility (data not shown; see Fig. 4).
Characterization of rLpE. yLpE was purified to homo-
geneity from human plasma by agarose gel electrophoresis
and subsequent anti-apoE affinity chromatography. After
io--
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isolation y-LpE still exhibited y mobility upon agarose gel
electrophoresis (Fig. 2a). On nondenaturing polyacrylamide
gel electrophoresis, y-LpE presented itselfas a disperse band
with an apparent particle size of 14 ± 3 nm (data not shown).
On electron microscopy, this lipoprotein appeared as a
homogenous spherical particle with a diameter of 12-16 nm
(Fig. 2b). Under both reducing and nonreducing conditions,
SDS/PAGE of y-LpE revealed the presence of a single
protein with an apparent molecular mass of 68 kDa that
reacted with both monoclonal and polyclonal antibodies
against apoE (Fig. 2c). The molecular mass is twice that

















expected for monomeric apoE. To rule out self-aggregation of
isolated apoE as the basis for this phenomenon, two-
dimensional electrophoresis in the order agarose gel electro-
phoresis -. SDS/PAGE was performed. Subsequent anti-
apoE immunoblotting revealed the presence in the y fraction
of an anti-apoE-immunoreactive protein with a molecular
mass of 34 kDa, which corresponds to that of monomeric
apoE (Fig. 2c). Analysis of the lipid composition revealed
that t-LpE consists of75% ± 4% protein, 5% ± 1% UC, 7%
± 2% phosphatidylcholine, and 13% ± 4% sphingomyelin.
Effect of apoA-I Deficiency and apoE Dfiiency on the
Uptake of Cell-Derived [3HJUC by rLpE. To test the impor-
tance of apoE for the uptake of cell-derived cholesterol into
a y-migrating lipoprotein, we repeated the pulse incubations
with [3H]cholesterol-loaded fibroblasts using plasma from
normal, apoA-I-deficient, and apoE-deficient mice (Fig. 3).
Like human plasma, normal murine plasma takes up [HIUC
from fibroblasts into lipoproteins with y (35% ± 6%), pre-fs
(7% ± 1%), and a-mobility (53% ± 6%) (Fig. 3a). When its
low cholesterol concentration is taken into account, murine
apoA-I-deficient plasma removed [3H]UC from cells as effi-
ciently as normal plasma (1820 ± 250 vs. 1882 ± 314 cpm/pg
of UC); the radioactivity was regularly distributed through-
out y-, pre-.3, and a-Lp (Fig. 3b). After pulse incubation of
[3H]UC-loaded fibroblasts with apoE-deficient plasma, the
specific radioactivity in the medium amounted to only 5% of
15
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FIG. 2. Characterization of -y.LpE. (a) Agarose gel electropho-
resis and immunoblotting ofapoA-I- or apoE-containing lipoproteins
in human plasma. Lane 1, anti-apoA-I immunoblot; lane 2, anti-apoE
immunoblot; lane 3, anti-apoE immunoblot of purified -tyLpE. (b)
Electron micrograph of purified y-LpE. (c) SDS/PAGE of y.-LpE.
Lane 1, low molecular mass standards. Lanes 2-5, SDS/PAGE of
y-LpE isolated from plasma by agarose gel electrophoresis and
subsequent anti-apoE immunoaffinity chromatography. Lanes 2 and
3, gel stained with Coomassie blue; lanes 4 and 5, anti-apoE
immunoblots. Under these conditions apoE presents itself as a
protein of 68 kDa, which is twice as high as expected. Lanes 6 and
7, agarose gel strips containing proteins with electrophoretic y
mobility were subjected to SDS/PAGE for subsequent anti-apoE
immunoblotting without prior elution of proteins. Under these con-
ditions, apoE is presented with its expected molecular mass of 34
kDa. In lanes 2, 4, and 6, proteins were reduced by incubation of
proteins or gel strips with mercaptoethanol. In lanes 3, 5, and 7,
SDS/PAGE was performed under nonreducing conditions. In lanes
3-7, immunodetection was performed with biotinylated sheep anti-
human apoE antibodies and streptavidin-horseradish peroxidase.
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FIG. 3. Distribution of cell-denved [3HJUC in various lipopro-
teins of plasma from normal, apoA-I-deficient, and apoE-deficient
mice. Normal (a), apoA-I-deficient (b), and apoE-deficient (c) plas-
mas were pulse incubated for 1 min with [3H]UC-loaded human skin
fibroblasts. Aliquots of 20 Ad of plasma were then subjected to
electrophoresis in 0.75% agarose gels. After electrophoresis, each
lane of the gel was cut into 5-mm-long segments. The lipids in each
slice were extracted with chloroform/methanol (2:1), and their
radioactivity was determined by liquid scintillation spectrometry.
The values given are the means ± SD of triplicate experiments.
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b C plasma prevents the formation of y-LpE and the uptake of
N A- E- N A- E- N A- E- cell-derived UC into this lipoprotein.
The Origin of 'LpE. To exclude the possibility that
fibroblasts themselves produce 'y-LpE, cell culture medium
derived from nonlabeled fibroblasts (fibroblast-conditioned
medium) was pulse incubated with radiolabeled fibroblasts
and subsequently separated by agarose gel electrophoresis.Ad Ac After incubation for up to 20 hr, no significant radioactivity
* w w* ad?was detectable in the y fraction of an agarose gel (Fig. 5a).
W -_ However, addition of 10 pig of 'y-LpE either to the fibroblast-
conditioned medium or directly to the radiolabeled fibro-
blasts resulted in significant accumulation of [3H]UC in a
FIG. 4. Agarose gel electrophoresis of lipoproteins from plasmas distinct y fraction after a 1-min incubation (Fig. 5b). We also
normal, apoA-I-deficient, and apoE-deficient mice. To prevent tested whether apoE-synthesizing cells produce -LpE. Me-
oss-reactions with the second antibody during immunodetection dium from either cultured mouse peritoneal macrophages
asma samples from normal (N), apoA-I-deficient (A-), and apoE- (Fig. Sc) or HepG2 cells (Fig. Sd) was pulse incubated for 1
ficient (E-) mice were depleted of IgG by protein G immunoaf- min with radiolabeled fibroblasts. Considerable amounts of
fity chromatography. Plasma samples were then separated by radiolabeled cholesterol were found associated with Y-mi-
,arose gel electrophoresis. The gels were either stained with fat red grating lipoproteins, suggesting that these cells indeed pro-
] (a) or electroblotted to nitrocellulose membranes for immunode- duce -LpE.
ove ad %Ace 11_ {AlAnd f-I left& +16- _e^ f and;' ALecLuon oi apou-ii t) ana apoh tc). iDole me aWsence oI anu-apor--
immunoreactive material in the v-fraction of apoE-deficient plasma
(c; E-).
that obtained after incubation with normal plasma (90 ± 9
cpm/pg of UC). No radioactivity was associated with pro-
teins of 'y mobility (Fig. 3c).
Fig. 4 demonstrates the electrophoretic separation of mu-
rine lipoproteins in normal, apoA-I-deficient, and apoE-
deficient plasma that was initially depleted of IgG by protein
G affinity chromatography. Lipid staining of the gel revealed
similar patterns in normal and apoA-I-deficient mice, but an
abnormal pattern with a broad ( band in apoE-deficient
plasma was observed (Fig. 4a). Western blotting revealed
anti-apoA-I-immunoreactive material in pre-f- and a-Lp
from normal and apoE-deficient plasma (Fig. 4b) and anti-
apoE-immunoreactive material in y-, pre-(-, and a-Lp from
normal and apoA-I-deficient plasma (Fig. 4c). The plasma of
apoE-deficient mice contained no anti-apoE or anti-apoA-I-
immunoreactive material associated with Emigrating pro-













In normal human plasma, apoE is a structural component of
chylomicrons, very low density lipoproteins, intermediate
density lipoproteins, and HDL1 among which it is exchanged
in response to metabolic changes of plasma lipids (23).
Furthermore, isolation of lipoproteins by various techniques
sometimes leads to the dissociation of apoE. For example,
ultracentrifugation of plasma at d < 1.21 g/ml leads to the
occurrence of some apoE unassociated with apoA-I or apoB
in the lipoprotein-free infranatant (24). By contrast, after
anti-apoE immunoaffmity chromatography of plasma, all
apoE was found associated with apoA-I or apoB. Therefore,
it was concluded that apoE is present in normolipidemic
plasma only as a component of apoA-I- and apoB-containing
lipoproteins. However, plasma of patients with familial lec-
ithin-cholesterol acyltransferase deficiency contains a dis-
coidal, apoE-containing lipoprotein that promotes choles-
terol efflux from fibroblasts (17, 25, 26). This study describes
the presence in normal human and murine plasma of a
1.
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FIG. 5. Electrophoretic distribution of cell-derived [3H]UC in conditioned media from various cells. One milliliter of fibroblast-conditioned
medium (a), fibroblast-conditioned medium plus 10 pg of y-LpE (b), macrophage-conditioned medium (c), or HepG2 cell-conditioned medium
(d) was incubated with radiolabeled fibroblasts for 1 min at 370C. Other experimental conditions correspond to those described in Fig. 1. Note
that medium from fibroblasts releases [3H]UC into a emigrating lipoprotein only if supplemented with yLpE (b). The values given are the means
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lipoprotein, y-LpE, that also contains apoE as the only
protein constituent and sphingomyelin as the major lipid
component. It is a spherical particle with a diameter of 12-16
nm and exhibits y mobility on agarose gel electrophoresis. It
is also a potent acceptor of cell-derived cholesterol.
In its ability to take up cell-derived UC and to subsequently
transfer it to a-HDL, t-LpE functionally resembles pre-pi-
HDL (pre-(31-LpA-I), a discoidal particle that contains
apoA-I as the only protein constituent and that has so far been
considered to be the only particle involved in the initial
uptake of cell-derived cholesterol (5). In our studies, y-LpE
contained in normal human and murine plasma samples took
up more cell-derived [3H]UC than pre-p3-LpA-I. To further
substantiate this important role of y-LpE in the uptake of
cellular cholesterol, [3H]UC-labeled human fibroblasts were
incubated with plasma from both apoA-I- and apoE-deficient
mice. In these experiments, plasma from apoA-I-deficient
mice regularly released cell-derived [3H]cholesterol into the
y-LpE fraction. By contrast, apoE-deficient murine plasma
failed to take up cell-derived [3H]UC into this lipoprotein
with ymobility. Moreover, the specific radioactivity released
from the cells by incubation with apoE-deficient plasma
amounted to only 5% of that obtained after incubation with
normal plasma, whereas apoA-I-deficient plasma released
regular amounts of specific radioactivity. These observations
strongly suggest that y-LpE is very important, at least in
murine plasma, in promoting cholesterol efflux from cells.
Furthermore, in contrast to apoA-I, which is synthesized
only by hepatocytes and enterocytes, apoE is secreted by a
broad variety of cells including macrophages (23, 27-29). This
ubiquity of apoE synthesis further supports an important role
of y-LpE in the removal of cholesterol from cells, and
possibly, thereby in the protection of the vessel wall from
atherosclerosis. Differentiated macrophages, which predom-
inate in the atherosclerotic plaque, increase their synthesis of
apoE when loaded with cholesterol (18, 28). In the present
study, we demonstrated that medium preconditioned by
incubation with cholesterol-loaded macrophages not only
releases [3H]UC from fibroblasts into a ymigrating lipopro-
tein but also releases [3H]UC from mouse peritoneal macro-
phages (data not shown). This indicates, as originally sug-
gested by Basu et al. (18), that macrophages may deplete
themselves of excess cholesterol by secretion of apoE. This
conclusion gains further support from the in vivo observa-
tions that infusion of apoE leads to the regression of athero-
sclerosis in LDL receptor-deficient Watanabe heritable hy-
perlipidemic rabbits (30) and that apoE-deficient mice but not
apoA-I-deficient mice suffer from atherosclerosis (31-33).
ApoE deficiency in mice (31, 32) and humans (34-36) might
thus cause atherosclerosis not only by impairment ofremnant
catabolism and hypercholesterolemia but also by impairing
the efflux of cholesterol from cells.
In conclusion, we have identified an apoE-containing li-
poprotein, 'yLpE, that takes part in the very early stages of
the uptake and transfer of cell-derived cholesterol by human
plasma. Since apoE is secreted by many cells including
arterial wall macrophages, the presence of y-LpE in plasma
may indicate a general mechanism by which cells rid them-
selves of excess cholesterol.
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